US Stock MarketDetailed Quotes

IVVD Invivyd

Watchlist
  • 1.220
  • +0.070+6.09%
Close Jul 22 16:00 ET
145.57MMarket Cap-652P/E (TTM)

About Invivyd Company

Invivyd, Inc.(formerly Adagio Therapeutics, Inc.) engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.

Company Profile

SymbolIVVD
Company NameInvivyd
Listing DateAug 6, 2021
Founded2020
CEOMr. William Duke, Jr
MarketNASDAQ
Employees95
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1601 Trapelo Road,Suite 178
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-819-0080
Websitehttp://www.adagiotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Stacy Price
  • Chief Technology and Manufacturing Officer
  • --
  • Robert Allen
  • Chief Scientific Officer
  • --
  • Julie Green
  • Chief Human Resources Officer
  • --
  • Jill Andersen
  • Chief Legal Officer and Corporate Secretary
  • 2.08M
  • William Duke, Jr
  • Principal Executive Officer, Chief Financial Officer and Principal Accounting Officer
  • --
  • Timothy Lee
  • Chief Commercial Officer
  • --
  • Marc Elia
  • Chairman of the Board
  • 138.63K
  • Tan Berry
  • Director
  • 93.13K
  • Sara Cotter
  • Director
  • 106.56K
  • Srishti Gupta
  • Independent Director
  • --
  • Kevin F. Mclaughlin
  • Independent Director
  • --
  • Terrance G. Mcguire
  • Independent Director
  • 97.13K
  • Christine Lindenboom
  • Independent Director
  • 80.44K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg